Blood Glucose Meter Market Space Reviewed in New MIC Research Study Recently Published at MarketPublishers.com
25 Jun 2015 • by Natalie Aster
LONDON – In the context of the growth in the global economy, the number of people with diabetes is rising on an annual basis in a number of countries and regions due to increased calorie and sugar intakes. With a blood glucose meter one can effectively control blood sugar levels in diabetic patients, which in turn contributes to the reduction of the risk of complications related to diabetes. Abbott, Dexcom, Baxter, Roche Diagnostics and Medtronic are amid the entrenched players in the marketplace. The US-based firms hold the majority of blood glucose meter patients. North America and Europe have the greatest demand, whilst India and China hold the largest potential.
New market research report “Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis” created by Market Intelligence & Consulting Institute (MIC) provides an in-depth analysis of, and outlook for the blood glucose meters market, giving a granular overview of both invasive and non-invasive blood glucose meters. It provides the relative R&D strength analysis of the 30 leading assignees (companies) in the blood glucose meters domain, as well as canvasses patent and strategic deployments of the 5 established industry players. A matrix analysis of the 10 most essential blood glucose meter patents is included.
Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis
Published: June, 2015
Price: US$ 800.00
More new comprehensive research reports by the publisher can be found at MIC page.